These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12591923)

  • 21. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Components of a Stat recognition code: evidence for two layers of molecular selectivity.
    Schindler U; Wu P; Rothe M; Brasseur M; McKnight SL
    Immunity; 1995 Jun; 2(6):689-97. PubMed ID: 7796300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process.
    Greenlund AC; Morales MO; Viviano BL; Yan H; Krolewski J; Schreiber RD
    Immunity; 1995 Jun; 2(6):677-87. PubMed ID: 7796299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization.
    Resetca D; Haftchenary S; Gunning PT; Wilson DJ
    J Biol Chem; 2014 Nov; 289(47):32538-47. PubMed ID: 25288792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergy between signal transducer and activator of transcription 3 and retinoic acid receptor-alpha in regulation of the surfactant protein B gene in the lung.
    Yang L; Lian X; Cowen A; Xu H; Du H; Yan C
    Mol Endocrinol; 2004 Jun; 18(6):1520-32. PubMed ID: 15044588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An SH2 domain model of STAT5 in complex with phospho-peptides define "STAT5 Binding Signatures".
    Gianti E; Zauhar RJ
    J Comput Aided Mol Des; 2015 May; 29(5):451-70. PubMed ID: 25752764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor.
    Coleman DR; Ren Z; Mandal PK; Cameron AG; Dyer GA; Muranjan S; Campbell M; Chen X; McMurray JS
    J Med Chem; 2005 Oct; 48(21):6661-70. PubMed ID: 16220982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation.
    Gamero AM; Sakamoto S; Montenegro J; Larner AC
    J Biol Chem; 2004 Mar; 279(13):12379-85. PubMed ID: 14722125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replication protein a 32 kDa subunit (RPA p32) binds the SH2 domain of STAT3 and regulates its transcriptional activity.
    Kim J; Kim D; Chung J
    Cell Biol Int; 2000; 24(7):467-73. PubMed ID: 10875894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity in recognition of phosphopeptides by src-homology 2 domains.
    Cantley LC; Songyang Z
    J Cell Sci Suppl; 1994; 18():121-6. PubMed ID: 7533766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction and analysis of SH2 domain-phosphopeptide interactions.
    Zvelebil MJ; Panayotou G; Linacre J; Waterfield MD
    Protein Eng; 1995 Jun; 8(6):527-33. PubMed ID: 8532676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
    Gram H; Schmitz R; Zuber JF; Baumann G
    Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor.
    Chakraborty A; Dyer KF; Cascio M; Mietzner TA; Tweardy DJ
    Blood; 1999 Jan; 93(1):15-24. PubMed ID: 9864141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells.
    Nagel-Wolfrum K; Buerger C; Wittig I; Butz K; Hoppe-Seyler F; Groner B
    Mol Cancer Res; 2004 Mar; 2(3):170-82. PubMed ID: 15037656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct interaction of STAT4 with the IL-12 receptor.
    Yao BB; Niu P; Surowy CS; Faltynek CR
    Arch Biochem Biophys; 1999 Aug; 368(1):147-55. PubMed ID: 10415122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cell-permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitro.
    Zhao W; Jaganathan S; Turkson J
    J Biol Chem; 2010 Nov; 285(46):35855-65. PubMed ID: 20807764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a STAT4 binding site in the interleukin-12 receptor required for signaling.
    Naeger LK; McKinney J; Salvekar A; Hoey T
    J Biol Chem; 1999 Jan; 274(4):1875-8. PubMed ID: 9890938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms.
    Park OK; Schaefer LK; Wang W; Schaefer TS
    J Biol Chem; 2000 Oct; 275(41):32244-9. PubMed ID: 10915797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.